QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.107.133710v1 325/2/417    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Arab, A. Articles by Hehrlein, C. Search for Related Content PubMed PubMed Citation Articles by Arab, A. Articles by Hehrlein, C.

CARDIOVASCULAR

Oxygenated Perfluorochemicals Improve Cell Survival during Reoxygenation by Pacifying Mitochondrial Activity

Departments of Cardiology (A.A., J.W., C.B., C.H.) and Environmental Science (K.K.), University of Freiburg, Freiburg, Germany

Perfluorochemicals (PFCs) are known to provide a unique tool for controlled uptake and delivery of oxygen. We have characterized the effects of incremental oxygen delivery on cell viability of human ischemic cardiomyocytes using chemically inert PFCs as oxygen carrier. We have found that cell viability after prolonged ischemia depends on the dose of oxygen supplementation by oxygenated (ox) PFCs during reoxygenation. Although reoxygenation with the transient addition of oxPFCs in high concentrations (2250 µMO₂ in 0.4 µM PFCs) results in decreased cell viability compared with normoxic reoxygenation, cell survival increases by 30 ± 4% after reoxygenation with moderate oxPFC concentrations (750 µM O₂ in 0.1 µM PFCs). Immunoblot analysis revealed that oxPFC-supplemented reoxygenation causes marked (16-fold) deactivation of death-associated protein kinase (DAPK) signaling an increase in mitochondrial membrane potential and a decreased steady-state level of superoxide by 19 ± 3%. Reoxygenation with oxPFCs is further responsible for a 2-fold activation of AMP-activated protein kinase (AMPK) signaling an inadequate ATP supply by oxidative phosphorylation during reoxygenation. Addition of oxPFCs stabilizes both hypoxia-inducible factor (HIF) 1- and 2- during reoxygenation. Overall, these results indicate that moderate doses of oxPFCs can improve cell survival during reoxygenation, causing deactivation of DAPK, up-regulation of AMPK, and HIF1- and 2- stabilization. These effects of oxPFCs are dose-dependent, and they lead to a stabilization of the mitochondrial membrane potential, decreased steady-state levels of superoxide, and pacification of mitochondrial activity.

Address correspondence to: Dr. Amina Arab, Department of Cardiology, University of Freiburg, Hugstetterstrasse 55, D-79106 Freiburg i. Br, Germany. E-mail: arab{at}medizin.ukl.uni-freiburg.de